Company / Current Liabilities per Share
Tarsus Pharmaceuticals, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$3.54
FY2025
5-year range
$0.56 / $3.54
FY2021-FY2025
Trend
+50.2%
vs FY2024
Sector context
#49 of 210
Health Care
What the data says
Tarsus Pharmaceuticals, Inc.'s current liabilities per share of $3.54 is higher than 77% of companies in the Health Care sector (FY2025). Current Liabilities per Share has increased for 4 consecutive years, from $0.56 in FY2021 to $3.54 in FY2025.
Based on SEC 10-K filings.
3.54 in FY2025 with a 5-year CAGR of +32.5%. Top quartile in the Health Care sector.
Increased from $1.38 to $3.54 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +68.1%
- 5-Year CAGR
- +32.5%
- 10-Year CAGR
- -
Sector benchmark
-85.1% below sector average
Key checks
Key Insights
- Tarsus Pharmaceuticals, Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 50.2% year-over-year.
- Ranks #49 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.54 | +50.2% |
| FY2024 | $2.36 | +70.3% |
| FY2023 | $1.38 | +85.6% |
| FY2022 | $0.75 | +32.0% |
| FY2021 | $0.56 | -34.9% |
| FY2020 | $0.87 | +150.4% |
| FY2019 | $0.35 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026